KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$0.21.

  • ClearPoint Neuro's EPS (Basic) fell 1666.67% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.84, marking a year-over-year decrease of 2173.91%. This contributed to the annual value of -$0.73 for FY2024, which is 1882.4% up from last year.
  • Per ClearPoint Neuro's latest filing, its EPS (Basic) stood at -$0.21 for Q3 2025, which was down 1666.67% from -$0.21 recorded in Q2 2025.
  • ClearPoint Neuro's EPS (Basic)'s 5-year high stood at -$0.13 during Q1 2021, with a 5-year trough of -$0.29 in Q2 2023.
  • In the last 5 years, ClearPoint Neuro's EPS (Basic) had a median value of -$0.18 in 2022 and averaged -$0.19.
  • The largest annual percentage gain for ClearPoint Neuro's EPS (Basic) in the last 5 years was 9980.0% (2021), contrasted with its biggest fall of 10005.77% (2021).
  • Over the past 5 years, ClearPoint Neuro's EPS (Basic) (Quarter) stood at -$0.19 in 2021, then increased by 2.73% to -$0.18 in 2022, then fell by 2.81% to -$0.19 in 2023, then fell by 9.98% to -$0.21 in 2024, then fell by 0.49% to -$0.21 in 2025.
  • Its last three reported values are -$0.21 in Q3 2025, -$0.21 for Q2 2025, and -$0.22 during Q1 2025.